4-Methylmorpholine → HCID 46837081, compound
Reaction equation
Cl.[NH2:2][CH2:3][CH2:4][O:5][C:6]1[CH:7]=[N:8][C:9]([C:12]2[CH:13]=[C:14]([CH:29]=[CH:30][CH:31]=2)[CH2:15][N:16]2[C:21](=[O:22])[CH:20]=[CH:19][C:18]([C:23]3[CH:24]=[N:25][N:26]([CH3:28])[CH:27]=3)=[N:17]2)=[N:10][CH:11]=1.[C:32]([NH:35][C@@H:36]([CH:40]([CH3:42])[CH3:41])[C:37](O)=[O:38])(=[O:34])[CH3:33].CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.CN1CCOCC1>CN(C=O)C.ClCCl.CO.O>[C:32]([NH:35][C@@H:36]([CH:40]([CH3:42])[CH3:41])[C:37]([NH:2][CH2:3][CH2:4][O:5][C:6]1[CH:7]=[N:8][C:9]([C:12]2[CH:31]=[CH:30][CH:29]=[C:14]([CH2:15][N:16]3[C:21](=[O:22])[CH:20]=[CH:19][C:18]([C:23]4[CH:24]=[N:25][N:26]([CH3:28])[CH:27]=4)=[N:17]3)[CH:13]=2)=[N:10][CH:11]=1)=[O:38])(=[O:34])[CH3:33]Participants
10
Reactant 5
Product 1
Reagents, catalysts & solvents 4
Procedure
100 mg (0.23 mmol) of 2-{3-[5-(2-aminoethoxy)pyrimidin-2-yl]benzyl}-6-(1-methyl-1H-pyrazol-4-yl)-2H-pyridazin-3-one hydrochloride, 43 mg (0.25 mmol) of (S)-2-acetylamino-3-methylbutyric acid, 66 mg (0.34 mmol) of EDCI, 41 mg (0.30 mmol) of HOBt are dissolved in 2 ml of DMF, and 76 μl (0.68 mmol) of 4-methylmorpholine are added. The reaction mixture is stirred at room temperature for 18 h, water is added, and the precipitate is stirred with methanol and dichloromethane. The product is dried in vacuo.
Workup
- customThe product is dried in vacuo
Sources & evidence
- ORD record
- ord-5a5a886d25454b0483bd85a4cd156513
- Source dataset
- uspto-grants-2014_01
- Patent number
- US08637518B2
Reaction notes
Loading…